InsidersTradesSigma
Track the 쓰리빌리언 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 쓰리빌리언 has recorded 33 reports. Market capitalisation: €161bn. The latest transaction was disclosed on 26 May 2026 (Purchase). Among the most active insiders: 한국산업은행. All data is openly available.
33
Insider Decl.
n/a
Thresholds
n/a
25 ops.
Buy Volume
n/a
6 ops.
Sell Volume
Fundamental score
Ranked 22,873 of 29,156 companies
31.8
score / 100
Value26
Quality38
FCF yld-3.6%
Earn yld-3.4%
EV/EBITDA·
ROE-29%
Gross mgn100%
Net mgn-46%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 26 May 2026
Declarations33 total
1,509,827 sharesKRXDART:20260109000362
25 of 33 declarations
About 쓰리빌리언
쓰리빌리언 is a healthcare and pharmaceutical company listed on the XKRX market. It focuses on developing innovative solutions to enhance patient health.